首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

歐洲神經刺激設備市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

市場調查報告書

商品編碼

1494504

歐洲神經刺激設備市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

Europe Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 91 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲神經刺激設備市值為17.1784億美元，預計2030年將達到34.5924億美元；預計2022年至2030年複合年成長率為9.1%。

脊髓損傷病例的增加推動了歐洲神經刺激設備市場

由於容易患各種脊椎疾病的老年人口不斷增加，神經刺激設備行業受到了關注。這些人變得更容易罹患脊椎疾病，如退化性椎間盤疾病、骨關節炎、脊椎側彎、脊椎腫瘤和椎管狹窄。隨著人口老化，脊椎的自然磨損會導致多種脊椎疾病。因此，鑑於這一事實，人口老化給脊椎外科醫生帶來了獨特的挑戰，因為身體虛弱、合併症、營養狀況下降以及術後併發症的可能性更高。根據世界衛生組織（WHO）2022年10月發布的資料，到2050年，約80%的老年人口將生活在低收入和中等收入國家，預計人口老化速度將大大加快。人口老化，加上生活方式相關因素，導致患有退化性椎間盤疾病和脊椎畸形等脊椎問題的人數大幅增加。因此，老年人和成年人脊髓損傷的高發生率刺激了對神經刺激設備的需求。

歐洲神經刺激設備市場概況

歐洲神經刺激設備市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。由於腦動脈瘤、中風等神經系統疾病的盛行率不斷上升，以及該地區市場參與者不斷增加的產品創新，預計該地區市場在未來幾年將顯著成長。市場成長也歸因於德國、法國和西班牙等國家醫療保健系統的發展以及主要區域公司推出的創新產品的增加。 2020年6月，美敦力宣布推出採用BrainsenseTM技術的PerceptTM PC神經刺激器。該技術同時記錄並向大腦傳送電刺激，以緩解帕金森氏症 (PD) 的症狀。

歐洲神經刺激設備市場收入及 2030 年預測（百萬美元）

歐洲神經刺激設備市場細分

歐洲神經刺激設備市場根據產品、應用、最終用戶和國家進行細分。

根據產品，歐洲神經刺激設備市場分為脊髓刺激器、深部腦部刺激器、薦神經刺激器、迷走神經刺激器等。 2022 年，脊髓刺激器細分市場佔據最大的市場。

從應用來看，歐洲神經刺激設備市場分為疼痛管理、癲癇、大小便失禁、巴金森氏症等。 2022 年，疼痛管理領域佔據最大的市場。

依最終用戶分類，歐洲神經刺激設備市場分為醫院、專科診所等。 2022 年，醫院細分市場佔據最大的市場。

根據國家/地區，歐洲神經刺激設備市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲神經刺激設備市場佔有率中佔據主導地位。

Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、ElectroCore Inc 和 Mainstay Medical 是歐洲神經刺激設備市場上的一些領先公司。

The neurostimulation devices industry has gained traction owing to the rising elderly population prone to various spinal disorders. These population is becoming more susceptible to developing spinal disorders such as degenerative disc diseases, osteoarthritis, scoliosis, spinal tumor, and spinal stenosis. As this population ages, the natural wear and tear of the spine can lead to several spinal disorders. Hence, with this fact, the aging population poses a unique challenge to spine surgeons due to multiple increased frailty, medical comorbidities, decreased nutritional status, and the higher probability of postoperative complications. According to the World Health Organization (WHO) data published in October 2022, approximately 80% of the elderly population will be living in low-and middle-income countries by 2050, and it is anticipated that the pace of this population aging will be much faster than in the past. The aging demographic, coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neurostimulation devices.

Europe Neurostimulation Devices Market Overview

The Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising prevalence of neurologic disorders such as cerebral aneurysms, stroke, and others and increasing product innovations made by the market players operating in the region. The market growth is also attributed to the development of healthcare systems in countries such as Germany, France, and Spain and rise in innovative product launches by key regional companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson's disease (PD).

Europe Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Neurostimulation Devices Market Segmentation

The Europe neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical are some of the leading companies operating in the Europe neurostimulation devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 ElectroCore Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Mainstay Medical
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)